Akèy › Atrofi Jeyografik
Etid klinik pou Atrofi Jeyografik ap rekrite nan Etazini
24 etid pou Atrofi Jeyografik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Dallas, TX8 etid
- Reno, NV8 etid
- Austin, TX7 etid
- Santa Monica, CA7 etid
- Naperville, IL6 etid
- The Woodlands, TX6 etid
- Cleveland, OH6 etid
- Baltimore, MD6 etid
- Houston, TX6 etid
- Washington, DC5 etid
- St. Louis, MO5 etid
- Spokane, WA5 etid
- Erie, PA5 etid
- San Antonio, TX5 etid
- Hagerstown, MD5 etid
- Sacramento, CA5 etid
- St. Petersburg, FL4 etid
- Fort Worth, TX4 etid
- Durham, NC4 etid
- Raleigh, NC4 etid
- Lynchburg, VA4 etid
- Nashville, TN4 etid
- Philadelphia, PA4 etid
- Los Angeles, CA3 etid
- Huntington Beach, CA3 etid
- Salt Lake City, UT3 etid
- Carmel, IN3 etid
- Boston, MA3 etid
- Pensacola, FL3 etid
- Syracuse, NY3 etid
- Escondido, CA3 etid
- Eugene, OR3 etid
- Cincinnati, OH3 etid
- Concord, CA3 etid
- Sarasota, FL3 etid
- Phoenix, AZ3 etid
- Lewisville, TX3 etid
- McAllen, TX3 etid
- Allentown, PA3 etid
- Abilene, TX3 etid
Pa eta
- Arizona5 etid
- Colorado4 etid
- Connecticut4 etid
- Florid8 etid
- Georgia4 etid
- Illinois9 etid
- Indiana3 etid
- Kalifòni13 etid
- Maryland7 etid
- Massachusetts7 etid
- Michigan5 etid
- Mississippi3 etid
- Missouri5 etid
- Nevada8 etid
- New Jersey3 etid
- New York4 etid
- North Carolina7 etid
- Ohio7 etid
- Oregon4 etid
- Pennsylvania9 etid
- South Carolina4 etid
- Tennessee4 etid
- Texas15 etid
- Utah4 etid
- Virginia4 etid
- Washington6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Ap rekriteFaz 2/3
Laj 60 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06635148Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
Ap rekriteFaz 1/2
Laj 55 a 95 · Tout sèks · Mizajou Sep 29, 2026 · NCT04339764A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 23, 2026 · NCT06557460A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Ap rekriteFaz 1/2
Laj 55 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07029945A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Ap rekriteFaz 1/2
Laj 60 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07215234A Study in Adults With Geographic Atrophy
Ap rekriteFaz 2
Laj 60 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 18, 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Ap rekriteEtid obsèvasyon
Laj 55 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07144137A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Ap rekriteFaz 1
Laj 50 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT03178149Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06662162SGLT2 Inhibitors in Geographic Atrophy
Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT07174687A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06659549Phase 1 Study of C.001 in Retinal Degeneration
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07594236Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Ap rekriteFaz 1
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07230834Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Ap rekriteFaz 1/2
Laj 50 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT07160179Stem Cell Ophthalmology Treatment Study II
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT03011541High Resolution Retinal Imaging
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT01866371Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
Ap rekriteEtid obsèvasyon
Laj 55 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT07556406Progression of Early Atrophic Lesions
Ap rekriteEtid obsèvasyon
Laj 50 ak plis · Tout sèks · Mizajou Mar 11, 2026 · NCT05959005A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD
Ap rekriteFaz 1/2
Laj 50 a 85 · Tout sèks · Mizajou Jan 23, 2026 · NCT07158775A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2025 · NCT06805474Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Dec 3, 2024 · NCT05438732Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.